← Back to all trials
Enrolling By Invitation
NCT07936188
Phase 2 Study of GC4006A in Healthy Adults
Conditions: Covid-19 Prevention
Sex: All
Ages: 19 Years – 85 Years
Healthy volunteers: Yes
Phase: PHASE2
Enrollment: 210
Sponsor: GC Biopharma Corp
Location: Korea University Guro Hospital Seoul Seoul
Summary
The purpose of this study is to evaluate the safety and immunogenicity of the COVID-19 preventive vaccine 'GC4006A' in healthy adults aged 19 to 85 years
Eligibility Criteria
Inclusion Criteria:
* Age 19-85 with written informed consent
* ≥16 weeks since last COVID-19 vaccination
Exclusion Criteria:
* Positive SARS-CoV-2 test (RT-PCR/Rapid Antigen) at screening or randomization
* \
Source: ClinicalTrials.gov (NCT07936188). StuddyBuddy aggregates publicly available trial information.